A ctivated fibroblasts are critically involved in both reparative and fibrotic processes. In normal tissues, resident fibroblasts are quiescent, producing limited amounts of extracellular matrix proteins and exhibiting few actin-associated cell-matrix and cell-cell contacts. 1 Tissue injury triggers alterations in the mechanical microenvironment and activates cytokine and growth factor-mediated pathways resulting in differentiation of fibroblasts into myofibroblasts, [2] [3] [4] phenotypically modulated cells characterized by the presence of a microfilamentous contractile apparatus enriched with ␣-smooth muscle actin (␣-SMA). In the healing wound, activated myofibroblasts are the main source of extracellular matrix proteins. 5, 6 Release of biologically active transforming growth factor (TGF)-␤1 plays an important role in activation of fibroblasts in wound repair, both by promoting myofibroblast transdifferentiation and by enhancing synthesis of extracellular matrix proteins. 7, 8 TGF-␤1 exerts many of its effects through a cascade of intracellular effectors, the Smads. 9 Extensive evidence suggests that activation of the Smad2/3 cascade plays an essential role in extracellular matrix protein gene expression 10 and regulates fibrous tissue deposition in a variety of experimental models. [11] [12] [13] Smad3 deficiency attenuates collagen deposition in a model of bleomycin-induced pulmonary fibrosis 14 and protects from the development of renal fibrosis after ureteral obstruction. 15 Experiments from our laboratory have demonstrated a critical role for Smad3 signaling in fibrotic remodeling of the infarcted heart. 16 Smad3 null mice had significantly reduced collagen deposition in the scar and in the remodeling noninfarcted ventricle and exhibited reduced dilative remodeling and attenuated diastolic dysfunction after myocardial infarction. 16 Although Smad3 is essential for the development of cardiac fibrosis, the mechanisms responsible for its profibrotic actions have not been systematically investigated.
Our current study examines the effects of Smad3 gene disruption on phenotype and function of cardiac fibroblasts. We found that Smad3 absence results in infiltration of the infarcted heart with a large number of cells that exhibit impaired functional properties and defective matrix synthetic capability. Smad3 null fibroblasts showed impaired myofibroblast transdifferentiation, reduced migratory potential, and reduced capacity to contract collagen pads on TGF-␤1 stimulation. Upregulation of the essential TGF-␤-induced fibrogenic mediator connective tissue growth factor (CTGF) in the infarcted myocardium was in part dependent on Smad3. Our findings suggest that Smad3 gene disruption abrogates the antiproliferative effects of TGF-␤1 in the infarcted heart and results in accumulation of abundant but functionally defective fibroblasts attenuating adverse fibrotic remodeling of the infarcted ventricle.
Methods
A detailed description of the methods is provided in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
All animal studies were approved by the animal protocol review committee at Baylor College of Medicine. Smad3Ϫ/Ϫ mice 16, 17 and wild-type (WT) C57/BL/6 controls underwent reperfused myocardial infarction experiments using a closed-chest model of coronary occlusion/reperfusion. 18 Sections from paraffin-embedded hearts were immunolabeled with anti-Ki-67 and anti-␣-SMA antibodies to allow identification of proliferating myofibroblasts. Identification of apoptotic cells was performed using fluorescent In situ Cell Death Detection Kit (Roche). 19 The collagen content in infarcted hearts network was assessed using picrosirius red staining and a hydroxyproline assay. Single-cell suspensions were prepared from infarcted hearts after 72 hours of reperfusion and underwent flow cytometric analysis of ␣-SMA and collagen I expression.
To investigate the role of Smad3 signaling in fibroblast phenotype and function, mouse fibroblasts from WT and Smad3Ϫ/Ϫ hearts were isolated by enzymatic digestion. Growth factor-stimulated cells were used for collagen lattice contraction assay, transwell migration assay, 19 cell proliferation assay, 19 immunofluorescence, flow cytometry, RNA, and protein extraction. Real-time PCR was used to assess expression of extracellular matrix proteins. ␣-SMA expression in infarcted hearts and isolated cells was assessed using established Western blotting protocols. 16 
Results

Smad3 Null Infarcts Exhibit Increased Myofibroblast Infiltration But Attenuated Collagen Deposition
␣-SMA immunofluorescence was used to identify infarct myofibroblasts as spindle-shaped immunoreactive cells located outside the vascular media ( Figure 1A and 1B). Smad3 absence resulted in formation of a highly cellular wound with reduced deposition of collagen. Quantitative analysis showed that Smad3 null mice had significantly increased cellular content and higher myofibroblast density in the infarcted heart ( Figure  1C through 1E) . Histochemical sirius red staining ( Figure 1G and1H) and a biochemical hydroxyproline assay ( Figure 1I ) demonstrated that despite the enhanced accumulation of myofibroblasts, collagen deposition was significantly reduced in Smad3 null infarcts. Flow cytometry using single-cell suspensions harvested from infarcted hearts after 72 hours of reperfusion confirmed the histological findings demonstrating that Smad3 null infarcts contained more cells and had a higher number of ␣-SMAϩ/collagen Iϩ myofibroblasts ( Figure 1F ). Assessment of mean fluorescent intensity for collagen I in infarct myofibroblasts demonstrated that cells isolated from Smad3 null infarcts had lower collagen content than WT cells ( Figure 1J and 1K ).
The Role of Smad3 in Cardiac Fibroblast Proliferation
To examine whether the increased myofibroblast density in Smad3 null infarcts is due to enhanced proliferative activity, we identified proliferating myofibroblasts using dual immunohistochemical staining for ␣-SMA and ki-67 (Figure 2A through 2F). Quantitative analysis showed that the density of proliferating myofibroblasts in the infarcted heart peaked after 72 hours of reperfusion ( Figure 2G ). Smad3 null mice had a significantly higher number of proliferating myofibroblasts per area of infarcted heart when compared with WT animals. However, when normalized to the total number of myofibroblasts present in the infarcted heart, the percentage of proliferating myofibroblasts was comparable between Smad3 null and WT mice ( Figure 2H ).
Antiproliferative Actions of TGF-␤1 on Isolated Cardiac Fibroblasts Are Dependent on Smad3
Serum-deprived Smad3Ϫ/Ϫ cardiac fibroblasts exhibited higher basal proliferative activity than corresponding WT cells ( Figure 2I ). TGF-␤1 stimulation reduced proliferation of serum-deprived WT murine cardiac fibroblasts in a dosedependent manner ( Figure 2I ). In contrast, TGF-␤1 did not significantly affect proliferation of Smad3 null fibroblasts (PϭNS), indicating that the antiproliferative effects of TGF-␤1 are reduced in the absence of Smad3.
WT and Smad3 Null Infarcts Exhibit Comparable Rates of Apoptosis
Termination of the fibrogenic response in tissue repair is dependent on apoptosis of wound fibroblasts. To examine whether increased myofibroblast density in Smad3 null infarcts is due to their reduced apoptosis during infarct maturation we identified apoptotic cells in the healing infarct using TUNEL staining ( Figure 3A through 3G) . The density of apoptotic cells per area of infarcted heart was comparable between WT and Smad3 null animals after 24 hours to 7days of reperfusion ( Figure 3H ). However, the percentage of nuclei exhibiting apoptosis was significantly lower in Smad3 null infarcts after 72 hours of reperfusion ( Figure 3I ). Dual fluorescence for TUNEL and ␣-SMA showed rare apoptotic myofibroblasts in the infarcted heart ( Figure 3G ). The relative absence of apoptotic 
TGF-␤1-Mediated Contraction of Fibroblast-Populated Collagen Lattices Is Partially Dependent on Smad3
To examine the effects of Smad3 absence on fibroblast function, we assessed the ability of Smad3 null cells to elicit wound contraction using an assay of fibroblast-populated collagen lattices ( Figure 4 ). In the absence of serum, WT fibroblasts induced more extensive lattice contraction than Smad3 null fibroblasts ( Figure 4A , 4D, and 4G). Stimulation with 5% serum induced marked lattice contraction in gels populated with WT or Smad3 null fibroblasts resulting in comparable changes in size between groups ( Figure 4B , 4E, and 4G). Although TGF-␤1 stimulation enhanced collagen contraction in both WT and Smad3 null fibroblasts; contraction was markedly attenuated in lattices populated with Smad3 null cells ( Figure 4C , 4F, and 4G). . Sections were counterstained with DAPI to label nuclei. C: Smad3Ϫ/Ϫ infarcts had significantly higher cellular content than WT infarcts after 72 hours to 7days of reperfusion. D, Myofibroblast density was also significantly higher in Smad3 null infarcts after 72 hours to 7days of reperfusion. E, Myofibroblasts were a significantly higher percentage of nucleated cells in Smad3 infarcts after 72 hours of reperfusion. F, Flow cytometric analysis using isolated single cell suspensions harvested from infarcted hearts after 72 hours of reperfusion confirmed that Smad3 null mice had significantly more cells and a higher number of a-SMAϩ/collagen Iϩmyofibroblasts per milligram of infarcted heart than WT animals. G through I, In contrast, collagen deposition in the infarcted and remodeling heart was attenuated in the absence of Smad3. Sirius red staining identified the collagen network in WT (G) and Smad3 null (H) infarcts. Quantitative analysis of collagen content using a hydroxyproline assay demonstrated markedly reduced collagen deposition in infarcted Smad3 null hearts after 72 hours and 7 days of reperfusion (I). J and K, Flow cytometry was used to quantitatively assess collagen content in infarct myofibroblasts after 72 hours of reperfusion. J, Histograms of collagen I fluorescent intensity for representative Smad3 null (black) and WT animals (white) are shown. K, Infarcted Smad3 null animals had significantly lower mean fluorescent intensity (MFI) for collagen type I in ␣-SMAϩ/collagen Iϩmyofibroblasts than WT animals (**PϽ0.01, *PϽ0.05 vs corresponding WT).
Smad3 Null Cardiac Fibroblasts Exhibit Reduced ␣-SMA Expression on Stimulation With TGF-␤1
To examine the role of Smad3 on phenotypic modulation of cardiac fibroblasts into myofibroblasts, we compared ␣-SMA expression in WT and Smad3 null cardiac fibroblasts on stimulation with TGF-␤1. WT cardiac fibroblasts showed robust upregulation of ␣-SMA mRNA after 24 hours of stimulation ( Figure 5A ); ␣-SMA mRNA synthesis was significantly attenuated in Smad3 null cells. Flow cytometric analysis ( Figure 5B and 5C) and Western blotting ( Figure 5D and 5E) confirmed the essential role of Smad3 in TGF-␤1-mediated ␣-SMA upregulation. Baseline mean fluorescent intensity was comparable between WT and Smad3 null cardiac fibroblasts ( Figure 5B ). TGF-␤1 stimulation for 24 hours significantly increased the mean intensity of ␣-SMA expression in WT but not in Smad3 null cardiac fibroblasts Figure 2 . The role of Smad3 in myofibroblast proliferation in vitro and in healing myocardial infarction. A through F, Dual immunohistochemical staining for ␣-SMA to identify myofibroblasts (red, arrow) and ki-67 to label proliferating cells (black, arrowhead) was used to examine the effects of Smad3 gene disruption on myofibroblast proliferation in the infarcted heart. Representative sections from WT (A, control; B, 1-hour ischemia/72-hour reperfusion; C, 1-hour ischemia/7-day reperfusion) and Smad3Ϫ/Ϫ (D, control; E, 1 hour ischemia/72 hour reperfusion; F, 1-hour ischemia/7-day reperfusion) animals are shown. G: The peak density of proliferating ki-67ϩ myofibroblasts (cells/mm2) was significantly higher in Smad3 null infarcts after 72 hours of reperfusion (**PϽ0.01 vs corresponding 24-hour experiment, #PϽ0.05 vs corresponding WT). H, The percentage of infarct myofibroblasts exhibiting ki-67 expression was increased after 72 hours of reperfusion (**PϽ0.01 vs corresponding 24-hour experiment) but was comparable between WT and Smad3 null animals. I, In vitro TGF-␤1 inhibited WT cardiac fibroblast proliferation in a dose-dependent manner (*PϽ0.05, **PϽ0.01 vs WT control). In contrast, TGF-␤1 did not significantly affect proliferation of Smad3 null fibroblasts (PϭNS). In comparison to WT cells, Smad3 null fibroblasts exhibited significantly higher proliferative activity for all experimental conditions (#PϽ0.05 vs corresponding WT cells).
( Figure 5C ). Western blotting demonstrated that TGF-␤1-induced ␣-SMA protein upregulation was abrogated in Smad3 null cells ( Figure 5D and 5E). Moreover, dual fluorescent staining for ␣-SMA and Alexa Fluor 694-labeled phalloidin showed that Smad3 absence results in impaired organization of the polymerized actin cytoskeleton and reduced incorporation of ␣-SMA-positive filaments ( Figure 5F through 5K) in TGF-␤1-stimulated fibroblasts.
In vivo studies using flow cytometric analysis demonstrated that Smad3 null infarct myofibroblasts had significantly lower ␣-SMA expression than WT cells (Online Supplement).
Smad3 Signaling Mediates Cardiac Fibroblast Migration
Incubation with 1% serum significantly increased cardiac fibroblast migration ( Figure 6A , 6B, and 6E). On stimulation with serum, Smad3 null cardiac fibroblasts had significantly diminished migratory activity when compared with WT cells (Figure 6 ). TGF-␤1 exerted a modest effect on migration of WT fibroblasts that did not reach statistical significance and had no effect on Smad3 null cells ( Figure 6E ).
TGF-␤1-Mediated Induction of Extracellular Matrix Protein Synthesis in Cardiac Fibroblasts Is Dependent on Smad3
TGF-␤1 induced marked upregulation of type I collagen ( Figure 7A ), type III collagen ( Figure 7B ), and fibronectin ( Figure 7C ) mRNA in WT cardiac fibroblasts that peaked after 4 hours of stimulation. TGF-␤1-induced extracellular matrix protein synthesis was significantly impaired in Smad3 null cardiac fibroblasts ( Figure 7A through 7C) .
Late But Not Early CTGF Upregulation in the Infarcted Heart Is Smad3-Dependent
Because CTGF is an important downstream effector of the profibrotic actions of TGF-␤, 7 we examined whether Smad3 loss results in reduced CTGF upregulation in healing myo- Figure 3 . Effects of Smad3 deficiency on cellular apoptosis in the infarcted heart. A through I, Dual fluorescence was performed to identify apoptotic nuclei with TUNEL staining (green, arrows) and ␣-SMA immunofluorescence to label myofibroblasts (red, arrowheads). Sections were counterstained with DAPI (blue). Representative sections from WT (A, 1-hour ischemia/24-hour reperfusion; B, 1-hour ischemia/72-hour reperfusion; C, 1-hour ischemia/7 days reperfusion) and Smad3 null infarcts (D, 1 hour ischemia/24 hour reperfusion; E, 1-hour ischemia/72-hour reperfusion; F, 1-hour ischemia/7-day reperfusion) are shown. G, Apoptotic ␣-SMAϩ myofibroblasts were very rarely found in the infarcted myocardium in both WT and Smad3 null animals (arrow), reflecting their rapid clearance from the infarcted heart or disruption of loss of the myofibroblast phenotype as the cells undergo apoptosis. H, Quantitative analysis showed that Smad3 null and WT infarcts had comparable number of apoptotic cells per surface area (PϭNS). I, The percentage of cells exhibiting apoptosis was significantly lower in Smad3 null infarcts after 72 hours of reperfusion (*PϽ0.05 vs WT).
cardial infarcts. In WT animals, reperfused infarction resulted in early upregulation of CTGF mRNA after 6 hours of reperfusion ( Figure 7D ). CTGF mRNA levels remained elevated after 24 to 72 hours of reperfusion. Although early CTGF upregulation was not affected by the absence of Smad3, CTGF expression after 24 to 72 hours of reperfusion was significantly reduced in Smad3 null infarcts ( Figure 7D ). Thus, sustained induction of CTGF expression in the infarcted heart was Smad3-dependent.
TGF-␤-Induced CTGF Upregulation in Cardiac Fibroblasts Is in Part Dependent on Smad3
TGF-␤1 upregulated CTGF synthesis by WT fibroblasts, peaking after 4 hours of stimulation ( Figure 7E ). Smad3 null fibroblasts had significantly attenuated CTGF induction on stimulation with TGF-␤1 ( Figure 7E ), indicating that TGF-␤1-mediated CTGF upregulation is, at least in part, Smad3-dependent.
CTGF Stimulates Synthesis of Fibrosis-Associated Genes by Cardiac Fibroblasts in a Smad3-Independent Manner
We next examined the effects of CTGF on cardiac fibroblast gene expression. Incubation with CTGF significantly enhanced type I collagen ( Figure 7F ), type III collagen ( Figure  7G ), and fibronectin ( Figure 7H ) mRNA synthesis by fibroblasts peaking after 4 hours of stimulation. Costimulation of fibroblasts with both CTGF and TGF-␤1 induced significantly higher extracellular matrix protein expression than each one of the mediators alone. CTGF induced comparable upregulation of collagen and fibronectin mRNA in WT and Smad3Ϫ/Ϫ cells, suggesting that its effects on cardiac fibroblasts are independent of Smad3 ( Figure 7F through 7H). In contrast, the stimulatory effects of CTGF and TGF-␤1 coincubation were significantly attenuated in Smad3 null cells.
Discussion
After myocardial infarction, cardiac fibroblasts migrate into the infarct border zone, where they proliferate and undergo myofibroblast transdifferentiation 20 -23 promoting contraction of the scar. Activated myofibroblasts are the main source of extracellular matrix proteins in the infarcted and remodeling heart. 6 We have previously demonstrated that selective activation of the TGF-␤/Smad3 pathway in the infarct border zone is critically involved in the pathogenesis of fibrotic cardiac remodeling and contributes to the development of diastolic dysfunction following reperfused infarction 16 by enhancing collagen deposition in the remodeling myocardium. We now report that several essential phenotypic and functional alterations of cardiac fibroblasts with a key role in development of fibrotic remodeling are dependent on Smad3 (Figure 8 ). In the absence of Smad3, the healing infarct is infiltrated by abundant but defective fibroblasts that exhibit disrupted myofibroblast transdifferentiation, diminished migratory capacity, and impaired contractile and matrixsynthetic function. The functional impairment of Smad3 null fibroblasts results in attenuated interstitial fibrosis of the remodeling ventricle. Surprisingly, reduced collagen deposition in remodeling infarcted Smad3 null hearts was associated with significantly increased peak myofibroblast density (Figure 1) . Expansion of the myofibroblast population in Smad3 null infarcts may be due to loss of the antiproliferative effects of TGF-␤. Although extensive evidence suggests that the TGF-␤/Smad3 pathway exerts growth-inhibitory effects on a variety of cell types, 24 its role in fibroblast proliferation appears to be dependent on the context and on the unique characteristics of fibroblasts populating various sites of injury. Thus, TGF-␤ induced proliferation in dermal fibroblasts but attenuated the proliferative response in oral fibroblasts; both responses were dependent on Smad3. 25, 26 In the mouse heart transgenic overexpression of a mutant human TGF-␤1 that prevents tethering of the latent complex to the extracellular matrix leading to enhanced TGF-␤ activity resulted in reduced fibroblast proliferation in the absence of injury, but markedly enhanced proliferative activity in the injured heart. 27 Our experiments demonstrated antiproliferative effects of TGF-␤ on cardiac fibroblasts in vitro; these actions were abrogated in the absence of Smad3 (Figure 3) . However, in vivo the proliferation index was comparable between Smad3 null and WT infarcts, suggesting that in the complex and dynamic environment of the healing infarct contextual factors may modulate the effects of TGF-␤/Smad3 signaling.
Because, as the wound matures, mesenchymal cell populations in the healing infarct are cleared through apoptosis, we examined the effects of Smad3 deficiency on apoptosis of granulation tissue cells. TUNEL staining demonstrated that the density of apoptotic cells was comparable between Smad3 null and WT animals; whereas the percentage of infarct cells exhibiting apoptosis was somewhat lower in Smad3 null infarcts after 72 hour of reperfusion (Figure 4) . Apoptotic myofibroblasts were rarely found in the infarcted heart, reflecting their rapid clearance by professional phagocytes or indicating loss of myofibroblast phenotype as the cells undergo apoptosis (Figure 3) .
Beyond its involvement in regulating the proliferative activity of fibroblasts in the healing infarct, Smad3 signaling also played an important role in their functional activation. The abundant myofibroblasts accumulating in Smad3 null infarcts showed marked impairment of key functional responses. In a wound contraction assay, collagen lattices populated with Smad3 null cardiac fibroblasts exhibited markedly attenuated gel contraction when compared with pads populated with WT cells (Figure 4) . Defective contractile function of Smad3Ϫ/Ϫ cardiac fibroblasts was associated with reduced expression of ␣-SMA mRNA and protein and with disturbed formation of contractile microfilaments on stimulation with TGF-␤, indicating impaired myofibroblast transdifferentiation ( Figure 5 ). The role of the Smad3 pathway in ␣-SMA transcription has been previously demonstrated in fibroblast populations from noncardiac tissues. 28 Experiments using embryonal mouse fibroblasts showed that receptor-regulated Smads, and in particular Smad3, are rate limiting for ␣-SMA enhancer activation. 29 In addition, transfection with a Smad3-expressing plasmid markedly increased ␣-SMA expression, whereas transfection with an antisense Smad3 plasmid attenuated ␣-SMA synthesis in rat pulmonary fibroblasts. 30 Thus, the Smad3 pathway appears to govern acquisition of the myofibroblast phenotype by fibroblasts in both reparative and fibrotic responses, and mediates TGF-␤-induced contraction of collagen gels. 31 Smad3 signaling is also involved in fibroblast migration. Using a transwell assay, we found that serum stimulation induced a robust migratory response in isolated cardiac fibroblasts, whereas the effects of TGF-␤1 were modest and statistically insignificant ( Figure 6 ). Smad3 absence attenuated serummediated fibroblast migration. The findings indicate that the highly proliferative Smad3 null cardiac fibroblasts infiltrating the infarcted myocardium exhibit impaired migratory capacity. Previous studies have suggested that signaling flux through Smad3 is critically involved in TGF-␤-mediated chemotaxis in cutaneous wound healing and in fibrotic processes. 32, 33 Smad3 absence also markedly reduced the matrix-synthetic ability of cardiac fibroblasts. Fibronectin and type I and type III collagen transcription was upregulated in cardiac fibroblasts on stimulation with TGF-␤1; this effect was markedly attenuated in the absence of Smad3 (Figure 7A through 7C) . These findings may explain the marked reduction in collagen deposition observed in infarcted Smad3 null hearts, despite the presence of abundant myofibroblasts (Figure 1 ). Previous studies have identified several extracellular matrix proteins as Smad-dependent TGF-␤ targets in human dermal and in mouse embryonal fibroblasts. 10 Beyond the attenuation of direct TGF-␤-mediated fibroblast responses, Smad3 gene disruption may reduce fibrosis by decreasing expression of CTGF, a TGF-␤-inducible fibrogenic mediator with a central role in the pathogenesis of fibrosis. 7 TGF-␤-mediated induction of CTGF is dependent on Smad3 in cutaneous fibroblasts, 34 and lesional skin from Smad3Ϫ/Ϫ mice showed reduced CTGF expression. 28 Our experiments showed that CTGF mRNA levels were markedly increased in the infarcted murine myocardium after 6 to 72 hours of reperfusion. Although the early peak of CTGF expression was not dependent on Smad3, CTGF levels during the proliferative phase of healing (after 24 to 72 hours of reperfusion) were markedly reduced in Smad3 null infarcts ( Figure 7 ). This observation may reflect different stimulatory signals responsible for CTGF induction or may indicate distinct cellular sources of CTGF at various stages of healing. The effects of late attenuation of CTGF induction in Smad3 null infarcts may be particularly important for the fibrotic response, diminishing the activity of infarct myofibroblasts that accumulate in the murine myocardium after 3 to 5 days of reperfusion. 18 Our in vitro studies demonstrated that CTGF stimulation induced intense upregulation of collagen and fibronectin synthesis by cardiac fibroblasts in a Smad3-independent manner (Figure 7) . Costimulation of WT cardiac fibroblasts with TGF-␤ and CTGF had additive effects on extracellular matrix protein expression. In contrast, in Smad3 null cells, CTGF stimulation, and costimulation with TGF-␤ and CTGF induced comparable collagen and fibronectin mRNA expression levels. Although a specific CTGF receptor . qPCR demonstrated that CTGF mRNA levels are markedly upregulated in the infarcted WT myocardium after 6 to 72 hours of reperfusion. Smad3 null mice had reduced CTGF expression after 24 to 72 hour of reperfusion; however, peak mRNA levels after 6 hour of reperfusion were comparable between WT and Smad3Ϫ/Ϫ infarcts. (**PϽ0.01, *PϽ0.05 vs WT sham. ##PϽ0.01 vs KO sham;ˆP Ͻ0.01; &PϽ0.05 vs corresponding WT). E, TGF-␤1-mediated CTGF upregulation was dependent in part on Smad3. TGF-␤1 stimulation upregulated CTGF synthesis by WT cardiac fibroblasts. Smad3 absence was associated with attenuated TGF-␤1-induced CTGF upregulation (**PϽ0.01 vs WT control; ##PϽ0.01 vs KO control; P Ͻ0.05 vs corresponding WT). F through H, CTGF markedly upregulated fibroblast-derived extracellular matrix protein mRNA synthesis in a Smad3-independent manner. CTGF induced comparable type I collagen (F), type III collagen (G), and fibronectin (H) mRNA upregulation in WT and Smad3 null cardiac fibroblasts. Costimulation of WT cardiac fibroblasts with TGF-␤1 and CTGF had an additive effect on extracellular matrix protein mRNA expression. In contrast, collagen and fibronectin mRNA synthesis in Smad3 null cells on costimulation with CTGF and TGF-␤1 was comparable with the levels of expression observed in CTGF-stimulated cells (**PϽ0.01; *PϽ0.05 vs WT control; ##PϽ0.01 vs KO control; P Ͻ0.05 vs corresponding WT).
has not been identified, CTGF functions are independent of the TGF-␤/Smad3 pathway and appear to be mediated through integrins, proteoglycans and the low density lipoprotein receptor-related protein. 7, 35 Whereas TGF-␤ causes the induction of skin fibrosis, CTGF is required for persistent fibrous tissue formation. 36 Moreover, CTGF is a necessary cofactor for activation of TGF-␤-mediated adhesive cascades in embryonic fibroblasts 37 and activates TGF-␤ signals by direct binding in the extracellular space. 38 Our findings contribute new information essential for understanding the role of the TGF-␤/Smad3 pathway in fibrotic cardiac remodeling. Despite its antiproliferative effects, Smad3 signaling promotes fibrogenic actions, essential in the pathogenesis of cardiac fibrosis mediating myofibroblast transdifferentiation and wound contraction, inducing fibroblast migration and upregulating synthesis of extracellular matrix proteins. In addition, activation of the Smad3 pathway results in upregulation of CTGF that further enhances the fibrogenic properties of infarct fibroblasts. Because Smad3 activation is primarily localized in the infarct border zone and in the adjacent remodeling myocardium, 16, 39 Smad3-mediated actions result in expansion of the fibrotic process into noninfarcted areas and accentuate diastolic dysfunction. Thus, Smad3 inhibition may be a promising therapeutic approach in conditions associated with fibrotic cardiac remodeling.
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